Introduction: The Access Paradox in Cell & Gene Therapy
Regulatory approval is a critical milestone, but it is not synonymous with patient access. Globally, developers...
Introduction: The Access Paradox in Cell & Gene Therapy
Regulatory approval is a critical milestone, but it is not synonymous with patient access. Globally, developers...
The emergence of cell therapies—particularly those derived from induced pluripotent stem cells (iPSCs)—represents one of the most transformative advances in modern medicine. Nowhere is...
